Skip to content

Clinical trials

Phase 3 Multiple Sclerosis trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Sclerosis Phase: Phase 3 Country / region: Denmark Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20063
20071
20081
20091
20101
20111
20131
20161
20171
20182
20202
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Active, not recruiting4
Terminated4
Recruiting1
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi4
Biogen3
Hoffmann-La Roche3
Novartis Pharmaceuticals3
Bayer2
Genzyme, a Sanofi Company2
Actelion1
Glostrup University Hospital, Copenhagen1
Haukeland University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Sclerosis20
Multiple Sclerosis, Relapsing-Remitting5
Multiple Sclerosis, Chronic Progressive4
Recurrence2
Neoplasm Metastasis1
Optic Neuritis1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.